August 24, 2009 – The nuclear reactor in Petten, The Netherlands, which supplies medical isotopes, is up and running again after a scheduled maintenance.

Covidien (COV.N) expects to begin receiving material from the reactor in Petten this weekend, the company said in a letter to hospital clients dated August 18 and posted on the U.S. Food and Drug Administration website on Thursday.

Covidien gets most of its isotopes from the reactor, processes the raw material known as molybdenum-99 or Mo 99, used for diagnostic imaging tests.

For more information: www.covidien.com


Additional Content

News | Molecular Imaging

Editor's Note: This article has been updated to correct an earlier version. Oct. 15, 2026 — GE HealthCare has announced ...

Time October 16, 2026
arrow
News | Radiation Oncology

Oct. 12, 2026 — RWJBarnabas Health and Rutgers Cancer Institute have earned a systemwide accreditation from the American ...

Time October 13, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET ...

Time October 06, 2026
arrow
News | PET Imaging

Sept. 22, 2026 — Researchers from the Keck School of Medicine of USC are developing a new “plug-and-play” platform that ...

Time September 23, 2026
arrow
News | Women's Health

Sept. 1, 2026 — On Sept. 24, 2026 at 1 p.m. EDT, Siemens Healthineers will present a webinar on "Advancing Women's ...

Time September 03, 2026
arrow
Subscribe Now